PVLA · Categories · Coverage

PVLA - Analyst coverage initiated

Palvella Therapeutics Inc. (PVLA) analyst coverage initiated - real-time wire coverage filtered to Coverage only.

Recent Coverage for PVLA

• 19d
  William Blair initiated coverage on Palvella Therapeutics

  William Blair initiated coverage of Palvella Therapeutics with a rating of Outperform
• 176d
  Stephens initiated coverage on Palvella Therapeutics with a new price target

  Stephens initiated coverage of Palvella Therapeutics with a rating of Overweight and set a new price target of $220.00
• 301d
  Mizuho initiated coverage on Palvella Therapeutics with a new price target

  Mizuho initiated coverage of Palvella Therapeutics with a rating of Outperform and set a new price target of $205.00
• 334d
  BTIG Research initiated coverage on Palvella Therapeutics with a new price target

  BTIG Research initiated coverage of Palvella Therapeutics with a rating of Buy and set a new price target of $167.00
• 335d
  Craig Hallum initiated coverage on Palvella Therapeutics with a new price target

  Craig Hallum initiated coverage of Palvella Therapeutics with a rating of Buy and set a new price target of $175.00
• 421d
  Oppenheimer initiated coverage on Palvella Therapeutics with a new price target

  Oppenheimer initiated coverage of Palvella Therapeutics with a rating of Outperform and set a new price target of $85.00
• 455d
  Raymond James initiated coverage on Palvella Therapeutics with a new price target

  Raymond James initiated coverage of Palvella Therapeutics with a rating of Outperform and set a new price target of $54.00
• 471d
  Truist initiated coverage on Palvella Therapeutics with a new price target

  Truist initiated coverage of Palvella Therapeutics with a rating of Buy and set a new price target of $56.00
• 574d
  Chardan Capital Markets initiated coverage on Palvella Therapeutics with a new price target

  Chardan Capital Markets initiated coverage of Palvella Therapeutics with a rating of Buy and set a new price target of $50.00
• 588d
  Stifel initiated coverage on Palvella Therapeutics with a new price target

  Stifel initiated coverage of Palvella Therapeutics with a rating of Buy and set a new price target of $45.00
• 607d
  Scotiabank initiated coverage on Palvella Therapeutics with a new price target

  Scotiabank initiated coverage of Palvella Therapeutics with a rating of Sector Outperform and set a new price target of $50.00
• 622d
  Canaccord Genuity initiated coverage on Palvella Therapeutics with a new price target

  Canaccord Genuity initiated coverage of Palvella Therapeutics with a rating of Buy and set a new price target of $39.00
• 637d
  TD Cowen initiated coverage on Palvella Therapeutics with a new price target

  TD Cowen initiated coverage of Palvella Therapeutics with a rating of Buy and set a new price target of $44.00
• 678d
  H.C. Wainwright initiated coverage on Palvella Therapeutics with a new price target

  H.C. Wainwright initiated coverage of Palvella Therapeutics with a rating of Buy and set a new price target of $38.00
• 686d
  Cantor Fitzgerald initiated coverage on Palvella Therapeutics

  Cantor Fitzgerald initiated coverage of Palvella Therapeutics with a rating of Overweight

Other PVLA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings